Search Result "Vandetanib"
Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Journal: Current Cancer Therapy Reviews
Volume: 3 Issue: 4 Year: 2007 Page: 236-241
Author(s): Teresa Troiani, Tina Cascone, John Heymach, Fortunato Ciardiello
Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy
Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 865-874
Author(s): Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Rita Ambrosio, Marzia Falanga, Cesare Gridelli
Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1640-1650
Author(s): F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi, S. Barni
New Targeted Therapies for Thyroid Cancer
Journal: Current Genomics
Volume: 12 Issue: 8 Year: 2011 Page: 626-631
Author(s): Alessandro Antonelli, Poupak Fallahi, Silvia M. Ferrari, Ilaria Ruffilli, Francesca Santini, Michele Minuto, David Galleri, Paolo Miccoli
Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 864-882
Author(s): Libero Santarpia,Giulia Bottai
The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5022-5032
Author(s): M. A. Bareschino, C. Schettino, G. Colantuoni, E. Rossi, A. Rossi, P. Maione, F. Ciardielloi, C. Gridell
Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3901-3913
Author(s): Massimo Di Maio,Alessandro Morabito,Maria Carmela Piccirillo,Gennaro Daniele,Pasqualina Giordano,Raffaele Costanzo,Claudia Sandomenico,Agnese Montanino,Gaetano Rocco,Francesco Perrone
Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2013 Page: 483-495
Author(s): Jose M.G. Saez
Molecular Targets in Malignant Pleural Mesothelioma Treatment
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 1235-1244
Author(s): Giulia Pasello, Adolfo Favaretto
Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 3919-3930
Author(s): A. Rossi, P. Maione, M. L. Ferrara, P. C. Sacco, C. Schettino, M. A. Bareschino, C. Gridelli